The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LuCarbo: A phase 1a/1b trial of 177Lu-PSMA-617 (LuPSMA) with carboplatin in advanced prostate cancer.
 
Praful Ravi
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst); Novartis (Inst); Telix Pharmaceuticals (Inst)
 
Wanling Xie
Consulting or Advisory Role - Convergent Therapeutics; Prostate Cancer Clinical Trial Consortium
 
Morgan Paul
Employment - Alcon (I); Dexcom (I)
 
Erin Healy
No Relationships to Disclose
 
Amanda Lilienfeld
No Relationships to Disclose
 
Nicole LaBrecque
No Relationships to Disclose
 
Andrew Wolanski
No Relationships to Disclose
 
Jolivette Ritzer
No Relationships to Disclose
 
Michael Serzan
No Relationships to Disclose
 
Alok Tewari
Stock and Other Ownership Interests - B.A.I. Biosciences; Inflammatix; Moderna Therapeutics; Teladoc
 
Heather Jacene
Honoraria - Blue Earth Diagnostics; Munrol
Consulting or Advisory Role - spectrum dynamics
Research Funding - Blue Earth Diagnostics (Inst); Boston Scientific (I); Lantheus Medical Imaging (Inst)
Travel, Accommodations, Expenses - Abbott Laboratories (I); Abiomed (I); Biotronik International (I); Medtronic (I)